IRS4 and breast cancer: For example, overexpression of insulin receptor substrate 4 (IRS4) drives a subset of breast cancers, while IRS1 and IRS2 are not oncogenic in these cancers, even though all three IRS proteins activate PI 3-kinase–Akt growth signalling.